期刊文献+

CD25^+细胞在鼻咽癌中的表达及与EBV的关系 被引量:2

Expression of CD25^+ lymphocytes in nasopharyngeal carcinoma and its association with EBV infection
下载PDF
导出
摘要 目的探讨CD25+细胞在鼻咽癌组织中的表达情况及EB病毒感染对CD25表达的影响。方法用免疫组织化学方法检测CD25+细胞在鼻咽癌组织和鼻咽慢性炎症组织中的表达情况,并用组织原位杂交技术检测EB病毒对其表达的影响。对照组选取鼻咽慢性炎症组织。结果CD25+淋巴细胞在鼻咽癌组织中比在鼻咽慢性炎症组织中的表达明显升高, 差异具有显著性意义(P<0.001),且在未分化癌中表达高于角化型癌和非角化型癌(P<0.05)。原位杂交显示EB病毒与 CD25+淋巴细胞高表达有关。结论 CD25+淋巴细胞在鼻咽癌组织中表达高于慢性炎症组织,EB病毒感染与CD25+淋巴细胞表达间存在相关性。 Objective To investigate the expression of CD25^+ lymphocytes in nasopharyngeal carcinoma (NPC) tissue and the influence of Epstein-Barr virus (EBV) infection on CD25 expression. Methods Immunohistochcmistry was used to detect CD25 expression in the NPC tissues and in situ hybridization employed to detect EBV infection with chronic nasopharyngitis tissue as the control sample. Results Significant difference was noted in the expression of CD25^+ lymphocytes between NPC and chronic inflammatory tissues. The expression was higher in undifferentiated NPC than in keratinizing squamous cell carcinoma and non-keratinizing carcinomas. The NPC tissue was all EBV-positive except for one sample,, which was identified as keratinizing carcinoma, but the control samples were all negative for EBV infection, which was correlated with CD25 expression. Conclusion The expression of CD25^+ lymphocytes is higher in NPC tissues and correlated to EBV infection.
作者 刘巍 韩慧霞
出处 《南方医科大学学报》 CAS CSCD 北大核心 2006年第1期94-97,共4页 Journal of Southern Medical University
基金 国家自然科学基金(39970784) 广东省科技攻关项目(2KM054015)
关键词 鼻咽癌 CD25 EB病毒 免疫组化 原位杂交 nasopharyngeal carcinoma CD25 Epstein-Barr virus immunohistochemistry in situ hybridization
  • 相关文献

参考文献2

二级参考文献6

  • 1王志新,张楚毅,陈维中,何冰,汪子厚.肺癌患者IL-2RmRNA表达的临床意义[J].中国肿瘤临床,1996,23(4):243-246. 被引量:1
  • 2徐仁宝 卢建 等.受体的基础和临床[M].上海:上海科学技术出版社,1992.198-221,304-311.
  • 3戴旭东,中国癌症研究进展,2000年,54页
  • 4杨镇,肿瘤免疫学,1998年,48页
  • 5刘振华,肿瘤预后学,1995年,195页
  • 6徐仁宝,受体的基础与临床,1992年,198-221,304-311页

共引文献21

同被引文献52

  • 1刘莉,姚军霞,丁乾,曹如波,王晶,黄士昂.鼻咽癌患者外周血CD4^+ CD25^(high)调节性T细胞分析[J].临床耳鼻咽喉科杂志,2005,19(20):929-931. 被引量:8
  • 2刘莉,姚军霞,丁乾,黄士昂.非霍奇金淋巴瘤患者外周血CD4^+CD25^(high)调节性T细胞研究[J].中国实验血液学杂志,2006,14(1):119-122. 被引量:30
  • 3夏明,刘昉,张寒冰,许安廷,解光.CD4^+C25^+Treg细胞与喉鳞状细胞癌的相关性研究[J].山东大学耳鼻喉眼学报,2006,20(2):139-142. 被引量:5
  • 4Brunkow ME,Jeffery EW, Hjerrild KA,Paeper B, Clark LB,Yasayko SA,Wilkinson JE, Galas D, Ziegler SF, Ramsdell F.Disruption of a new forkhead/ winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet.2001, 27(1):68-73.
  • 5Wu Y, Borde M, He is smeyer V, et al. Foxp3 controis regulatory T cell function through cooper ation with NFAT[J].Cell, 2006, 125(2):375-387.
  • 6Chen W,Jin W, Hardegen N, et al.Conver sion of peripheral CD4+CD25 4-naive T cells Io C1M+CD25+ regulatory T cells by TGFB induction of transcription factor Foxp3[J]. J Exp Med, 2003,198(12). 1875-1886.
  • 7Gershon RK,Kondo K.Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunol, 1970,18:723-737.
  • 8Wolf AM, Wolf D, Steurer M, et al. Increase of regulatory T cell in the peripheral blood of cancer patents[J]. Clin Cancer Res, 2003, 9(2):606-612.
  • 9Paust S, Cabtor H.Regulatory T ceils and autoimmune disease[J].Immunol Rev. 2005,204:195-207.
  • 10Chakraborty NG,Chattopadhyay S, Mehrotra S, et al. Regulatory T-ceU response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma. Hum Immunol, 2004,55(8):794-802.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部